Subtype
Kidney and Ureter Neoplasm
CI-CAN-00001051Explore in graph →
Non-malignant518 active trials17 approved drugs81 evidence items
- NCIt
- C7514
Loading cancer entity…
Subtype
CI-CAN-00001051Explore in graph →
Clinical trials
2,410 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00203866 | Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 40 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00059813 | Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00757614 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom |
| unknown |
| — |
| 14,000 |
| Cancer Research UKOTHER |
| 1 |
| Aug 26, 2013 |
| clinicaltrials |
| NCT00100906 | Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer | completed | Phase 2 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT00858975 | Study of Cryotherapy for Renal Tumors | withdrawn | N/A | 0 | National Taiwan University HospitalOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT00492258 | Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer | completed | Phase 3 | 1,656 | Medical Research CouncilOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00626509 | Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 110 | Gruppo Italiano Carcinoma RenaleOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00873236 | MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer | unknown | Phase 2 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00900536 | DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | completed | — | — | Medical Research CouncilOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01024205 | Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer | completed | Phase 2 | 43 | Barts and the London School of Medicine and DentistryOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01105364 | Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer | unknown | N/A | 50 | National Cancer Institute, FranceOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00027664 | Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 90 | Cancer Research UKOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00025103 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | unknown | Phase 2 | 75 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 2, 2013 | clinicaltrials |
| NCT00323739 | Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma | completed | Phase 2 | 80 | SCRI Development Innovations, LLCOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00039052 | Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer | completed | Phase 1 | — | Neurocrine BiosciencesINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00557830 | Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 12 | Accelerated Community Oncology Research NetworkOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00678119 | Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment | completed | Phase 2 | 25 | Argos TherapeuticsINDUSTRY | 2 | Jul 15, 2013 | clinicaltrials |
| NCT01079286 | Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers(I-NET) | completed | Phase 1 | 18 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00025519 | Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 11, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00040989 | BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer | withdrawn | Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00502034 | Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. | completed | Phase 3 | 310 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00588913 | Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases | completed | Phase 1 / Phase 2 | 20 | Tokyo Women's Medical UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00896467 | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | terminated | — | 200 | Centre Oscar LambretOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01073644 | Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | terminated | — | 3 | PfizerINDUSTRY | 1 | Jul 4, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01892059 | Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy | unknown | N/A | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00098618 | Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | terminated | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00005056 | Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | completed | Phase 2 | — | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00030342 | Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer | completed | Phase 1 / Phase 2 | 60 | St. Luke's Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003542 | Interferon Alfa in Treating Patients With Advanced Kidney Cancer | completed | Phase 1 / Phase 2 | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00012337 | ZD 1839 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00016939 | Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00093405 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003390 | 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00003551 | Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer | completed | Phase 2 | — | Emory UniversityOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00005045 | Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 3 | Jun 21, 2013 | clinicaltrials |
| NCT00002466 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00082914 | Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00635791 | Phase I Study of Vorinostat and Sorafenib in Advanced Cancer | completed | Phase 1 | 36 | University of Colorado, DenverOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005069 | Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020527 | Caspofungin Acetate in Treating Children With Fever and Neutropenia | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00066599 | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01834183 | Tivozanib + Gemcitabine in Metastatic RCC | withdrawn | Phase 2 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00018941 | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | — | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00002473 | Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00262886 | Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer | completed | Phase 2 | 35 | University of RochesterOTHER | 1 | Jun 6, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Sep 5, 2013source: clinicaltrials